» Articles » PMID: 30994574

Partner Status Moderates the Relationships Between Sexual Problems and Self-efficacy for Managing Sexual Problems and Psychosocial Quality-of-life for Postmenopausal Breast Cancer Survivors Taking Adjuvant Endocrine Therapy

Overview
Journal Menopause
Date 2019 Apr 18
PMID 30994574
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Past studies indicate that >90% of breast cancer survivors taking adjuvant endocrine therapy (AET) experience menopausal symptoms including sexual problems (eg, vaginal dryness, dyspareunia); however, research examining the impact of these problems on quality-of-life is limited. This cross-sectional study examined (1) the impact of sexual problems and self-efficacy for coping with sexual problems (sexual self-efficacy) on quality-of-life (ie, psychosocial quality-of-life and sexual satisfaction), and (2) partner status as a moderator of these relationships.

Methods: Postmenopausal breast cancer survivors taking AET completed measures of sexual problems (Menopause-Specific Quality-of-Life [MENQOL] sexual subscale], sexual self-efficacy, psychosocial quality-of-life (MENQOL psychosocial subscale), and sexual satisfaction (Functional Assessment of Cancer Therapy-General item).

Results: Bivariate analyses showed that women reporting greater sexual problems and lower sexual self-efficacy had poorer quality-of-life and less sexual satisfaction (all P-values < 0.05). Partner status moderated the relationship between sexual problems and psychosocial quality-of-life (P = 0.02); at high levels of sexual problems, unpartnered women experienced poorer psychosocial quality-of-life than partnered women. Partner status also moderated the relationship between self-efficacy and psychosocial quality-of-life (P = 0.01). Self-efficacy was unrelated to psychosocial quality-of-life for partnered women; for unpartnered women, low self-efficacy was associated with poorer quality-of-life. Partner status did not moderate the relationships between sexual problems or self-efficacy with sexual satisfaction.

Conclusions: Greater sexual problems and lower sexual self-efficacy were associated with poorer psychosocial quality-of-life and sexual satisfaction among postmenopausal breast cancer survivors taking AET. Interventions to address sexual problems and sexual self-efficacy, particularly among unpartnered women, may be beneficial for improving the well-being of postmenopausal breast cancer survivors on AET.

Citing Articles

Sexual desire and erotic fantasies questionnaire: development and validation of the sexual desire scale (SDEF1).

Nimbi F, Galizia R, Ciocca G, Bratina Zimic A, Jannini E, Simonelli C Int J Impot Res. 2024; .

PMID: 38926631 DOI: 10.1038/s41443-024-00942-2.


A longitudinal study of sexual activity and influencing factors in breast cancer patients during treatment in the Southwest of China: a trajectory analysis model.

Tian Z, Xiaolu Z, Jing Y, Min W, Jiaqian L, Shouli C BMC Womens Health. 2024; 24(1):352.

PMID: 38890676 PMC: 11184704. DOI: 10.1186/s12905-024-03150-8.


Cancer therapy-related vaginal toxicity: its prevalence and assessment methods-a systematic review.

Claes M, Tuts L, Robijns J, Mulders K, Van De Werf E, Bulens P J Cancer Surviv. 2024; .

PMID: 38383907 DOI: 10.1007/s11764-024-01553-y.


Clinical Practice Strategies to Address Sexual Health in Female Cancer Survivors.

Arring N, Barton D, Reese J J Clin Oncol. 2023; 41(31):4927-4936.

PMID: 37535889 PMC: 10617876. DOI: 10.1200/JCO.23.00523.


Couples' sexual health after gynaecological cancer diagnosis - an unexplored area for further research.

Nowosielski K, Palka A Contemp Oncol (Pozn). 2023; 27(1):47-56.

PMID: 37266338 PMC: 10230241. DOI: 10.5114/wo.2023.127308.


References
1.
Wagner L, Zhao F, Goss P, Chapman J, Shepherd L, Whelan T . Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group.... Breast Cancer Res Treat. 2018; 169(3):537-548. PMC: 6092930. DOI: 10.1007/s10549-018-4713-2. View

2.
Derogatis L, Rosen R, Leiblum S, Burnett A, Heiman J . The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther. 2002; 28(4):317-30. DOI: 10.1080/00926230290001448. View

3.
Hilditch J, Lewis J, Peter A, van Maris B, Ross A, Franssen E . A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas. 1996; 24(3):161-75. DOI: 10.1016/s0378-5122(96)82006-8. View

4.
Lorig K, Chastain R, Ung E, Shoor S, HOLMAN H . Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum. 1989; 32(1):37-44. DOI: 10.1002/anr.1780320107. View

5.
Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A . Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial. J Clin Oncol. 2004; 22(21):4261-71. DOI: 10.1200/JCO.2004.08.029. View